Scholar Rock (SRRK)
(Delayed Data from NSDQ)
$31.96 USD
+0.56 (1.78%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $31.95 -0.01 (-0.02%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth C Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Scholar Rock Holding Corporation's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
SRRK 31.96 +0.56(1.78%)
Will SRRK be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SRRK based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SRRK
Should You Buy Scholar Rock Holding Corporation (SRRK) After Golden Cross?
SRRK Stock Soars as Muscle Disease Drug Meets Phase III Study Goal
SRRK: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for SRRK
Scholar Rock Holding (SRRK) Sees Price Target Revision by BMO Capital | SRRK Stock News
Decoding Scholar Rock Holding Corp (SRRK): A Strategic SWOT Insight
Q2 2025 Scholar Rock Holding Corp Earnings Call Transcript
SRRK Crosses Below Key Moving Average Level
Scholar Rock outlines Q3 2025 U.S. apitegromab launch plans amid regulatory progress and global expansion focus